EXPRS2 in a Range? EXPRS2 in a Range?
Expres2ion Biotech Holding - Short Term - We look to Sell at 25.70 (stop at 27.50)
Trading within a Bearish Channel formation. Closed below the 20-day EMA . The primary trend remains bearish . We expect prices to stall close to our bespoke level (26.50). Further downside is expected although we prefer to set shorts at our bespoke resistance levels at 26.50, resulting in improved risk/reward.
Our profit targets will be 20.44 and 16.20
Resistance: 26.50 / 30.00 / 35.00
Support: 20.00 / 15.00 / 10.00
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
Latest Market Insights
Quarterly Outlook Q3 2022: The Runaway Train
- Central banks' attempts to kill inflation is a paradigm shift, which could end in a deep recession.
Tangible assets and profitable growth are the winners
Understanding the lack of investment appetite among oil majors
The pressure is on as the wind leaves the sails
Why the Fed can never catch up and what turns the US dollar lower?
Bank of Japan: Swimming against the tide
Green transformation detour and bear market hibernation
Crisis redux for the eurozone?
Technical Outlook: Gold, Oil and a remarkable multi-decade perspective on Equities
China: the train of new development paradigm left the station two years ago